BSECompany Update3d ago · 11 Nov 2026, 05:44 pm
Submission of Statement of Deviation or Variation under Reg 32 for the quarter ended 30th September, 2026
Godavari Drugs Ltd · 530317
✦ AI SummaryResults
Godavari Drugs Ltd submitted a statement on deviation or variation in utilisation of funds for the quarter ended 30th September, 2026, as per Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Godavari Drugs Ltd - 530317 - Statement Of Deviation Or Variation For The Quarter Ended 30Th September, 2026